Safety and Efficacy of IDP-118 in Participants With Plaque Psoriasis
Public ClinicalTrials.gov record NCT02462122. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Safety and Efficacy of IDP-118 in the treatment of plaque psoriasis
Study identification
- NCT ID
- NCT02462122
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 215 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 19, 2015 (Actual)
- Primary completion
- Nov 9, 2016 (Actual)
- Completion
- Nov 14, 2016 (Actual)
- Last update posted
- Oct 20, 2026
2015 – 2016
United States locations
- U.S. sites
- 16
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Valeant Site 5 | Fremont | California | 94536 | — |
| Valeant Site 2 | Boynton Beach | Florida | 33424 | — |
| Valeant Site 14 | North Miami Beach | Florida | 33160 | — |
| Valeant Site 13 | Detriot | Michigan | 48201 | — |
| Valeant Site 8 | Warren | Michigan | 48088 | — |
| Valeant Site 10 | Fridley | Minnesota | 55421 | — |
| Valeant Site 1 | East Windsor | New Jersey | 08520 | — |
| Valeant Site 4 | Albuquerque | New Mexico | 87103 | — |
| Valeant Site 12 | New York | New York | 10001 | — |
| Valeant Site 6 | High Point | North Carolina | 27260 | — |
| Valeant Site 3 | Portland | Oregon | 97201 | — |
| Valeant Site 7 | Knoxville | Tennessee | 37909 | — |
| Valeant Site 9 | College Station | Texas | 77840 | — |
| Valeant Site 15 | Houston | Texas | 77001 | — |
| Valeant Site 16 | Houston | Texas | 77001 | — |
| Valeant Site 11 | Pflugerville | Texas | 78660 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02462122, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 20, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02462122 live on ClinicalTrials.gov.